• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远处转移性乳腺癌患者的相关疾病手术。

Disease-related surgery in patients with distant metastatic breast cancer.

机构信息

Cantonal Hospital Winterthur, Department of Gynecology and Obstetrics, Brauerstrasse 15, CH-8401 Winterthur, Switzerland; Breast Center "SenoSuisse", Brauerstrasse 15, CH-8401 Winterthur, Switzerland.

出版信息

Eur J Surg Oncol. 2013 Nov;39(11):1192-8. doi: 10.1016/j.ejso.2013.08.015. Epub 2013 Sep 10.

DOI:10.1016/j.ejso.2013.08.015
PMID:24029666
Abstract

INTRODUCTION

This study evaluates the frequency of and indications for disease-related surgical procedures in the palliative breast cancer (BC) situation.

PATIENTS & METHODS: Based on a cohort of women who were treated for newly diagnosed BC during a 20-year period (1990-2009), we analyzed 340 patients who developed distant metastatic disease (DMD) until 2011 and died (i.e. still ongoing palliative disease courses were not included).

RESULTS

One hundred and twenty-seven surgical procedures were performed in 100 patients (29.4% of all patients with metastatic disease). The most common site for surgery was breast (n = 60, 47.2%). The primary tumor was removed at first diagnosis of DMD in 43 patients (33.9%); sixteen operations (12.6%) were performed for local recurrence. In 37 patients, 50 surgical procedures (39.4%) were necessary to stabilize osseous structures due to metastases. Procedures were rarely performed on other common metastatic sites: lung: n = 1 (0.8%); liver: n = 1 (0.8%), brain: n = 4 (3.1%). When excluding surgery for primary breast tumors at initial diagnosis of DMD from analysis, 34 of 84 surgeries (40.4%) were performed in the first third of survival follow-up (i.e. period of metastatic disease survival); operations in the last two-thirds each totaled 29.8% (n = 25). The median survival after surgery was 16 months (range: 0.5-89 months).

CONCLUSIONS

In a cohort of BC patients who had primary or developed secondary DMD, nearly one third of the patients received disease-related surgical procedures during their palliative disease course. This high rate of operations shows that surgery has a clearly established role in the palliative therapy concept.

摘要

简介

本研究评估了在姑息性乳腺癌(BC)情况下与疾病相关的手术的频率和适应证。

患者与方法

基于在 20 年间(1990-2009 年)接受新诊断的 BC 治疗的女性队列,我们分析了 340 名在 2011 年之前发生远处转移疾病(DMD)并死亡的患者(即不包括仍在进行的姑息性疾病过程)。

结果

在 100 名患有转移性疾病的患者中进行了 127 次手术(所有转移性疾病患者的 29.4%)。最常见的手术部位是乳房(n=60,47.2%)。在 43 名患者中(33.9%),在首次诊断 DMD 时即切除了原发肿瘤;16 例手术(12.6%)用于局部复发。在 37 名患者中,由于转移,50 例手术(39.4%)用于稳定骨骼结构。很少在其他常见的转移性部位进行手术:肺:n=1(0.8%);肝:n=1(0.8%),脑:n=4(3.1%)。当从分析中排除在初始 DMD 诊断时切除原发性乳腺癌的手术时,84 次手术中的 34 次(40.4%)在生存随访的前三分之一(即转移性疾病生存期)进行;后两个三分之一各进行了 29.8%(n=25)。手术后的中位生存时间为 16 个月(范围:0.5-89 个月)。

结论

在一组患有原发性或继发性 DMD 的 BC 患者中,近三分之一的患者在姑息性疾病过程中接受了与疾病相关的手术。这种高手术率表明手术在姑息治疗概念中具有明确的作用。

相似文献

1
Disease-related surgery in patients with distant metastatic breast cancer.远处转移性乳腺癌患者的相关疾病手术。
Eur J Surg Oncol. 2013 Nov;39(11):1192-8. doi: 10.1016/j.ejso.2013.08.015. Epub 2013 Sep 10.
2
[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].[晚期三阴性乳腺癌患者的治疗结果及临床病理特征]
Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4.
3
Association of surgery with improved survival in stage IV breast cancer patients.手术与IV期乳腺癌患者生存率提高之间的关联。
Ann Surg. 2008 May;247(5):732-8. doi: 10.1097/SLA.0b013e3181656d32.
4
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.老年常见转移性恶性肿瘤患者的姑息化疗:希腊合作肿瘤学组关于管理、结局及临床获益预测因素的登记分析
Crit Rev Oncol Hematol. 2008 Jun;66(3):237-47. doi: 10.1016/j.critrevonc.2007.12.003. Epub 2008 Feb 1.
5
Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?对于初诊时即为 IV 期乳腺癌的女性,局部区域性肿瘤治疗能否改善其结局?
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):39-45. doi: 10.1016/j.ijrobp.2011.11.046. Epub 2012 Feb 11.
6
Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.保乳手术和放疗作为乳腺钼靶检测到的乳腺导管原位癌的初始治疗后局部复发的挽救性治疗。
Cancer. 2001 Mar 15;91(6):1090-7.
7
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.伴有肝转移的转移性乳腺癌:500例女性患者的临床病理、治疗及预后特征的登记研究
Breast Cancer Res Treat. 2006 Jun;97(3):237-44. doi: 10.1007/s10549-005-9117-4. Epub 2005 Dec 2.
8
Presence of symptoms and timing of surgery do not affect the prognosis of patients with primary metastatic breast cancer.症状的出现和手术时机并不影响原发性转移性乳腺癌患者的预后。
Eur J Surg Oncol. 2011 Oct;37(10):883-9. doi: 10.1016/j.ejso.2011.07.004. Epub 2011 Aug 16.
9
Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.局部晚期非炎性乳腺癌的联合化疗与术前放疗:120例患者的最新结果
Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1062-73. doi: 10.1016/j.ijrobp.2003.12.034.
10
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.IV期乳腺癌且原发肿瘤完整患者的原发肿瘤切除效果
Ann Surg Oncol. 2006 Jun;13(6):776-82. doi: 10.1245/ASO.2006.03.033. Epub 2006 Apr 17.

引用本文的文献

1
CT-guided microwave ablation in patients with lung metastases from breast cancer.CT 引导下微波消融治疗乳腺癌肺转移瘤。
Thorac Cancer. 2021 Dec;12(24):3380-3386. doi: 10.1111/1759-7714.14212. Epub 2021 Nov 2.
2
Contralateral Axillary Nodal Metastases: Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?对侧腋窝淋巴结转移:IV 期疾病还是局部进展性晚期乳腺癌的表现?
Ann Surg Oncol. 2021 Oct;28(10):5544-5552. doi: 10.1245/s10434-021-10461-9. Epub 2021 Jul 21.